JAGSNPHARM

JAGSONPAL PHARMACEUTICALS

Small Cap BSE: 507789 NSE: JAGSNPHARM
₹386.9
6.1 (1.6%)
As on 16 August, 2022 | 21:02

Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Jagsonpal Pharmaceuticals Share Returns

  • Over 1 Month 9.29%
  • Over 3 Month 34.62%
  • Over 6 Month 119.7%
  • Over 1 Year 124.22%

Jagsonpal Pharmaceuticals Key Statistics

P/E Ratio 77.3
PEG Ratio -2
Market Cap Cr 1,014
Price to Book Ratio 7.7
EPS 7.5
Dividend 1.3
Relative Strength Index 69.06
Money Flow Index 84.22
MACD Signal 10.08
Average True Range 21.17

Jagsonpal Pharmaceuticals Investment Rating

  • Master Rating:
  • Jagsonpal Pharmaceuticals has an operating revenue of Rs. 226.69 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 12% is healthy, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 53% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 14% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jagsonpal Pharmaceuticals Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 61
  • 52
  • 54
  • 59
  • 60
  • 43
  • Operating Expenses Qtr Cr
  • 54
  • 52
  • 49
  • 49
  • 51
  • 38
  • Operating Profit Qtr Cr
  • 6
  • 1
  • 6
  • 10
  • 9
  • 5
  • Depreciation Qtr Cr
  • 0
  • 1
  • 0
  • 0
  • 0
  • 0
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 2
  • 3
  • 3
  • 2
  • Net Profit Qtr Cr
  • 0
  • 0
  • 5
  • 7
  • 7
  • 5

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
386.9
6.1 (1.6%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 355.39
  • 50 Day
  • 335.16
  • 100 Day
  • 307.55
  • 200 Day
  • 250.1
  • 20 Day
  • 355.15
  • 50 Day
  • 327.11
  • 100 Day
  • 317.01
  • 200 Day
  • 249.78

Jagsonpal Pharmaceuticals Resistance and Support

PIVOT
₹381.79
Resistance
  • First Resistance
  • 389.02
  • Second Resistance
  • 397.24
  • Third Resistance
  • 404.47
Support
  • First Resistance
  • 373.57
  • Second Resistance
  • 366.34
  • Third Resistance
  • 358.12
  • RSI
  • 69.06
  • MFI
  • 84.22
  • MACD Single Line
  • 10.08
  • MACD
  • 11.84

Jagsonpal Pharmaceuticals Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 75,563
  • 2,956,780
  • 39.13
  • Week
  • 154,161
  • 4,880,745
  • 31.66
  • 1 Month
  • 74,075
  • 3,246,685
  • 43.83
  • 6 Month
  • 241,278
  • 9,667,997
  • 40.07

Jagsonpal Pharmaceuticals Result Highlights

Jagsonpal Pharmaceuticals Synopsis

NSE-Medical-Diversified

Jagsonpal Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 187.95 Cr. and Equity Capital is Rs. 13.10 Cr. for the Year ended 31/03/2021. Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181.
  • Market Cap
  • 1,014
  • Sales
  • 227
  • Shares in Float
  • 0.81
  • No of funds
  • 4
  • Yield
  • 1.05
  • Book Value
  • 7.67
  • U/D Vol ratio
  • 1.7
  • LTDebt / Equity
  • Alpha
  • 0.36
  • Beta
  • 1.11

Jagsonpal Pharmaceuticals

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 68.71%
  • 68.71%
  • 70.34%
  • Financial Institutions/ Banks
  • Individual Investors
  • 25.26%
  • 22.92%
  • 23.7%
  • Others
  • 6.03%
  • 8.37%
  • 5.96%

Jagsonpal Pharmaceuticals Management

  • Name
  • Designation
  • Mr. R P S Kochhar
  • Chairman & Managing Director
  • Mr. Manish Gupta
  • Managing Director
  • Ms. Radhika Madhukar Dudhat
  • Independent Director
  • Mr. Prithipal Singh Kochhar
  • Non Executive Director
  • Mr. Harsha Raghavan
  • Non Executive Director
  • Mr. Debasis Bikash Nandy
  • Independent Director
  • Ms. Pallavi Dinodia Gupta
  • Independent Director

Jagsonpal Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jagsonpal Pharmaceuticals Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-09
  • Quarterly Results
  • 2022-05-30
  • Audited & Quarterly Results
  • 2022-05-13
  • Others
  • 2022-02-11
  • Quarterly Results
  • (Revised) per share(2%)Dividend (Revised)
  • 2021-10-19
  • Quarterly Results & Interim Dividend
  • Date
  • Purpose
  • Remarks
  • 2021-11-01
  • INTERIM
  • Rs.4.00 per share(80%)Interim Dividend

Jagsonpal Pharmaceuticals FAQs

What is Share Price of Jagsonpal Pharmaceuticals ?

Jagsonpal Pharmaceuticals share price is ₹386 As on 16 August, 2022 | 20:48

What is the Market Cap of Jagsonpal Pharmaceuticals ?

The Market Cap of Jagsonpal Pharmaceuticals is ₹1013.6 Cr As on 16 August, 2022 | 20:48

What is the P/E ratio of Jagsonpal Pharmaceuticals ?

The P/E ratio of Jagsonpal Pharmaceuticals is 77.3 As on 16 August, 2022 | 20:48

What is the PB ratio of Jagsonpal Pharmaceuticals ?

The PB ratio of Jagsonpal Pharmaceuticals is 7.7 As on 16 August, 2022 | 20:48

Q1FY23